Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 8/20 | 0.58 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.58 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.58 |
| ▸ | HINT1 | P49773 | 1/20 | 0.54 |
| ▸ | NT5E | P21589 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | PNP | P00491 | 1/20 | 0.53 |
| ▸ | GSK3A | P49840 | 2/20 | 0.51 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.51 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.51 |
| ▸ | TGM2 | P21980 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16822243 | 0.98 | STING1 (0.58) | STING1PDE3BPDE3AHINT1NT5E | |
| SCHEMBL5571313 | 0.98 | STING1 (0.58) | STING1PDE3BPDE3AHINT1NT5E | |
| SCHEMBL21162740 | 0.98 | STING1 (0.58) | STING1PDE3BPDE3AHINT1NT5E | |
| SCHEMBL19417833 | 0.86 | STING1 (0.52) | STING1PDE3BPDE3AHINT1NT5E | |
| SCHEMBL20673214 | 0.83 | ADORA3 (0.52) | STING1PDE3BPDE3AADORA3 | |
| SCHEMBL24772604 | 0.83 | STING1 (0.49) | STING1PDE3BPDE3AHINT1NT5E | |
| SCHEMBL5698879 | 0.82 | HINT1 (0.63) | HINT1NT5EPNPGSK3ARPS6KA3 | |
| SCHEMBL7030275 | 0.82 | HINT1 (0.63) | HINT1NT5EPNPGSK3ARPS6KA3 | |
| SCHEMBL28772469 | 0.81 | STING1 (0.56) | STING1ADORA3GSK3ARPS6KA3MAPK14 | |
| SCHEMBL13833323 | 0.81 | HINT1 (0.62) | STING1PDE3BPDE3AHINT1NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0788507-B1 | L-PYRANOSYL NUCLEOSIDES | GENENCOR INT (US) | 2004-12-15 | — | — | EP | claimed |
| EP-1019423-B1 | METHOD FOR PRODUCING A PENTOPYRANOSYL NUCLEOSIDE | NANOGEN RECOGNOMICS GMBH (DE) | 2003-02-26 | — | — | EP | claimed |
| US-5885972-A | ANTICARCINOGENIC AGENT | GENENCOR INTERNATIONAL, INC. (US) | 1999-03-23 | — | — | US | claimed |
| EP-0788507-A1 | L-PYRANOSYL NUCLEOSIDES | GENENCOR INTERNATIONAL, INC. (US) | 1997-08-13 | — | — | EP | claimed |
| WO-1996012728-A1 | L-PYRANOSYL NUCLEOSIDES | GENENCOR INTERNATIONAL, INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0788507-B1 | L-PYRANOSYL NUCLEOSIDES | GENENCOR INT (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1017704-A2 | USE OF A PENTOPYRANOSYL NUCLEOSIDE CONTAINING CONJUGATE FOR PRODUCING AN ARRAY | Nanogen Recognomics GmbH (DE) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999015541-A2 | USE OF A PENTOPYRANOSYL NUCLEOSIDE FOR PRODUCING AN ELECTRONIC COMPONENT, AND CONJUGATES OF SAID PENTOPYRANOSYL NUCLEOSIDE | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-04-01 | — | — | WO | disclosed |
| US-5885972-A | ANTICARCINOGENIC AGENT | GENENCOR INTERNATIONAL, INC. (US) | 1999-03-23 | — | — | US | disclosed |
| EP-0788507-A1 | L-PYRANOSYL NUCLEOSIDES | GENENCOR INTERNATIONAL, INC. (US) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996012728-A1 | L-PYRANOSYL NUCLEOSIDES | GENENCOR INTERNATIONAL, INC. (US) | 1996-05-02 | — | — | WO | disclosed |